Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02523027
Other study ID # DA11
Secondary ID
Status Completed
Phase Phase 2/Phase 3
First received August 12, 2015
Last updated March 12, 2018
Start date June 21, 2016
Est. completion date August 2017

Study information

Verified date March 2018
Source Abbott Nutrition
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will investigate the effect of two oral nutritional supplements (ONS) along with dietary counseling vs dietary counseling alone on growth among picky eating children from India, aged > 24 months to ≤ 48 months over a period of 90 days.


Description:

Study Objective:

To investigate the effect of two oral nutritional supplements (ONS) along with dietary counseling vs dietary counseling alone on growth among picky eating children from India, aged > 24 months to ≤ 48 months over a period of 90 days.

Number of Subjects / Length of Participation:

Approximately 321 subjects (107 subjects per group) will be enrolled from estimated 8-10 study centers to obtain at least 255 evaluable subjects (85 subjects per group), assuming 20% attrition rate. Expected total duration for the study is approximately 12 months.

Study Design :

- Prospective, randomized, double blinded study, with two parallel treatment groups and an open-labeled control group multicenter clinical study Eligible subjects will be randomized into three groups

- Experimental Group 1: Oral nutritional supplement and dietary counseling. (List No S691/Z0)

- Experimental Group 2: Oral nutritional supplement and dietary counseling. (List No- P968/Z0)

- Control Group: Dietary counseling.


Recruitment information / eligibility

Status Completed
Enrollment 321
Est. completion date August 2017
Est. primary completion date February 17, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 2 Years to 4 Years
Eligibility Inclusion Criteria:

1. Child is > 24 months and = 48 months of age at visit 1.

2. Child of either gender (Male and Female).

3. Child has a weight-for-height between 3rd - 15th percentiles according to current WHO Growth Charts at visit 1. (WHO Growth Chart 2007)

4. Child is a picky eater, defined as meeting at least two of the following criteria. A child, who:

- eats only a limited number of foods

- is unwilling to try new foods

- refuses to eat vegetables and/or foods from other food groups

- shows strong food likes and dislikes

- has behaviors that disrupt mealtime

5. Child is a habitual milk drinker at least 1 glass (approximately 200mL) of milk daily.

6. Child is able to consume foods and beverages orally.

7. Child's Legal Guardian (LG) or parent(s) is willing to abstain from giving additional non-study nutritional supplements including vitamin/mineral supplements, micronutrient fortified beverages, oral nutritional supplements other than the study product during the study intervention period.

8. Child's Legal Guardian (LG) or parent(s) has voluntarily signed and dated an informed consent form (ICF), approved by an Independent Ethics Committee/Institutional Review Board (IEC/IRB) prior to any participation in the study.

9. Child's Legal Guardian (LG) or parent(s) is able and willing to follow study procedures and record data in parent diary and complete any forms or assessments needed throughout the study.

10. Child's Legal Guardian (LG) or parent(s)is not planning to relocate during the study period

Exclusion Criteria:

1. Child has been diagnosed with Lactose Intolerance & Galactosemia according to medical records or Legal Guardian (LG) /parent report.

2. Child has been diagnosed or is known to be allergic or intolerant to any ingredient found in the study product according to medical records or Legal Guardian (LG)/parent report.

3. Child has a current acute or chronic infection including respiratory infection, diarrhea, acute or chronic, Hepatitis B or C, HIV infection or tuberculosis according to medical records or Legal Guardian (LG)/parent report.

4. Child has been diagnosed with presence of severe gastrointestinal disorders including celiac disease, short bowel syndrome, pancreatic insufficiency, or cystic fibrosis according to medical records or Legal Guardian (LG)/parent report.

5. Child has been diagnosed with neoplastic, renal, hepatic or cardiovascular disease according to medical records or Legal Guardian (LG) /parent report.

6. Child has been diagnosed with hormonal or metabolic disorders according to medical records or Legal Guardian (LG) /parent report.

7. Child has been diagnosed with congenital disease or genetic disorders such as atrial or ventricular wall defects, or Down's syndrome according to medical records or Legal Guardian (LG) /parent report.

8. Child has been diagnosed with infantile anorexia nervosa according to medical records or Legal Guardian (LG) /parent report.

9. Child has been diagnosed with a developmental disability, including physical disorders such as cerebral palsy, or developmental delay according to medical records or Legal Guardian (LG) /parent report.

10. Child has been diagnosed with disorders of hemoglobin structure, function or synthesis according to medical records or Legal Guardian (LG) /parent report.

11. Child has a clinically significant nutritional deficiency requiring specific treatment with another nutritional supplement (other than the study product) as diagnosed by the investigator.

12. Child has any other clinically significant medical condition, which in the investigator's opinion, makes him or her unsuitable for inclusion in the study.

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Oral nutritional supplement (List No S691/Z0)
(List No S691/Z0)
Oral nutritional supplement
(List No- P968/Z0)
Other:
Dietary Counselling
Regular dietary counseling conducted by a trained hospital dietitian.

Locations

Country Name City State
India Sangini Hospital Ahmedabad Gujarat
India Kanchi Kamakoti Child Trust Hospital Chennai Tamil Nadu
India St. Theresa's Hospital Hyderabad Erragadda, Sanath Nagar
India Institute of Child Health Kolkata West Bengal
India Ajanta Research Centre, Ajanta Hospital & IVF Centre Lucknow Uttar Pradesh
India JSS Medical College & Hospital Mysore Karnataka
India Jehangir Clinical Development Centre, Jehangir Hospital Pune Maharashtra
India Medipoint Hospitals Pune Maharashtra
India Noble Hospital Pune Maharashtra
India Sterling Multispeciality Hospital Pune Maharashtra
India Praveen Cardiac Centre Vijayawada Andhra Pradesh

Sponsors (1)

Lead Sponsor Collaborator
Abbott Nutrition

Country where clinical trial is conducted

India, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in WHO weight-for-height percentile Day 1 to Day 90
Secondary Change in weight-for-height WHO z-score Day 1 to Day 90
Secondary Change in weight-for-age WHO z-score and percentile Day 1 to Day 90
Secondary Change in height-for-age WHO z-score and percentile Day 1 to Day 90
Secondary Change in BMI-for-age WHO z-score and percentile Day 1 to Day 90
Secondary Change in Mid Upper Arm Circumference-for-age WHO z-score and percentile Day 1 to Day 90
Secondary Average energy macronutrients (Carbohydrates, Fats, & Proteins) and micronutrients consumption via 24 hr dietary recall Days 1, 7, 30, 60 and 90
Secondary Change in appetite score Days 1, 7, 30, 60 and 90
Secondary Palatability scores for the oral nutritional supplements Days 7, 30, 60 and 90
Secondary Change in weight-for-height WHO z-score and percentile Day 1 to Day 90
Secondary Average energy macronutrients (Carbohydrates, Fats, & Proteins) and micronutrients consumption via 24 hr dietary recall Day 1, 7, 30, 60 and 90